Hydroxychloroquine, Azithromycin, and Zinc Triple-Combo Proved to be Effective in Coronavirus Patients, Study Says
(Science Times, May 2020)
The antimalarial drug candidate for coronavirus has long been introduced as a ‘game-changer’ in treating COVID-19 patients. However, in recent studies, contrasting results have been seen in patients. Some claim to have improved their condition with the help of the drug, while others blame the cure for the adverse reactions it brings.
A new study from New York suggests that the drug may yield better results when used in combination with the dietary supplement, zinc. Researchers from the NYU Grossman School of Medicine placed a medical preprint on their site on Monday. Their paper is yet to be peer-reviewed.
In the study, half of 900 COVID-19 patients were given the triple-drug combo of hydroxychloroquine, zinc, and azithromycin. The other half were given only hydroxychloroquine and the antibiotic, azithromycin.
The results of the study revealed that the patients who received the triple-drug combo had a 1.5 times greater probability of getting better from the disease…
READ Full Article →
A new study from New York suggests that the drug may yield better results when used in combination with the dietary supplement, zinc. Researchers from the NYU Grossman School of Medicine placed a medical preprint on their site on Monday. Their paper is yet to be peer-reviewed.
In the study, half of 900 COVID-19 patients were given the triple-drug combo of hydroxychloroquine, zinc, and azithromycin. The other half were given only hydroxychloroquine and the antibiotic, azithromycin.
The results of the study revealed that the patients who received the triple-drug combo had a 1.5 times greater probability of getting better from the disease…
Lancet, NEJM Retract Studies Debunking Hydroxychloroquine →